SCHEMBL8329893

SCHEMBL8329893

O=C(O)C(Cc1ccccc1)c1ccc(OCc2ccccc2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 1/20 0.52
PTPN12 Q05209 1/20 0.52
PTPN13 Q12923 1/20 0.52
SSU72 Q9NP77 1/20 0.52
PPARA Q07869 2/20 0.52
PPARD Q03181 1/20 0.52
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
MRGPRX4 Q96LA9 8/20 0.48
P4HTM Q9NXG6 1/20 0.48
HPGD P15428 3/20 0.47
TP53 P04637 2/20 0.47
XBP1 P17861 2/20 0.47
MEN1 O00255 1/20 0.47
MITF O75030 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38659146 0.80 ACP1 (0.53) ACP1PTPN12PTPN13SSU72NPC1
SCHEMBL9416618 0.79 MMP1 (0.55) SMN1; SMN2KMT2ARXRAHTT
SCHEMBL8332027 0.77 PPARG (0.64) PPARAPPARDP4HTM
SCHEMBL10172543 0.77 NPC1 (0.52) ACP1PTPN12PTPN13SSU72NPC1
SCHEMBL8768182 0.77 NPC1 (0.52) ACP1PTPN12PTPN13SSU72NPC1
SCHEMBL7142420 0.77 KMT2A (0.61) PPARASMN1; SMN2MEN1KMT2A
SCHEMBL2510091 0.76 SLC7A5 (0.54) ACP1PTPN12PTPN13SSU72NPC1
SCHEMBL7611564 0.76 ACP1 (0.49) ACP1PTPN12PTPN13SSU72NPC1
SCHEMBL5569175 0.76 ALOX5 (0.47) PPARAMRGPRX4RXRARXRB
SCHEMBL7611570 0.75 ACP1 (0.51) ACP1PTPN12PTPN13SSU72NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
WO-1998025605-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed